A new monoclonal antibody called nebokitug offers fresh hope to patients who have primary sclerosing cholangitis (PSC), ...
A multicenter study led by UC Davis Health has tested a new treatment designed to improve care for people with a rare liver ...
A new monoclonal antibody treatment has shown promising results for a rare liver disease called primary sclerosing ...
China NMPA grants marketing approval for Innovent Biologics' Tyvyt, a CTLA-4 monoclonal antibody: San Francisco Saturday, December 27, 2025, 16:00 Hrs [IST] Innovent Biologics Inc ...
In a randomized clinical trial, vixarelimab demonstrates dose-dependent, long-term safety and efficacy in patients with ...
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, ...
Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that it has received IND clearance from the U.S. Food and Drug Administration (FDA ...
Researchers have reported encouraging results from a clinical trial of a new monoclonal antibody therapy for primary ...
DECLARATION is a Phase 3, randomized, placebo-controlled clinical trial to evaluate the safety and efficacy of VYD2311 in the prevention of COVID ...
TipRanks on MSN
Invivyd’s COVID antibody VYD2311 receives FDA fast track
The latest announcement is out from Invivyd ( (IVVD) ).
The recent safety review of two approved RSV preventive treatments for infants initiated by the U.S. Food and Drug ...
Morning Overview on MSN
Antibody injections could replace slow IV drips for many treatments
For patients who rely on monoclonal antibodies and other biologic drugs, treatment often means hours tethered to an IV pole ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results